Share chart Candel Therapeutics, Inc.
Extended chart
Simple chart
About Candel Therapeutics, Inc.
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. more detailsIPO date | 2021-07-27 |
---|---|
ISIN | US1374041093 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.candeltx.com |
Цена ао | 7.5 |
Change price per day: | -4.26% (5.17) |
---|---|
Change price per week: | -2.85% (5.095) |
Change price per month: | -43.94% (8.83) |
Change price per 3 month: | -38.13% (8) |
Change price per half year: | -15.67% (5.87) |
Change price per year: | -9.01% (5.44) |
Change price per 3 year: | +1.23% (4.89) |
Change price per year to date: | +9.76% (4.51) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Northpond Ventures, Llc | 1935215 | 6.59 |
Sands Capital Ventures, LLC | 811737 | 2.77 |
Vanguard Group Inc | 425749 | 1.45 |
FMR, LLC | 298384 | 1.02 |
Geode Capital Management, LLC | 139253 | 0.47 |
Bridgeway Capital Management, Inc. | 132595 | 0.45 |
Baystate Wealth Management LLC | 76910 | 0.26 |
Blackrock Inc. | 49285 | 0.17 |
OneDigital Investment Advisors LLC | 29783 | 0.1 |
State Street Corporation | 27600 | 0.09 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Dr. Seshu Tyagarajan Ph.D. | Chief Technical & Development Officer | 335.27k | 1968 (57 years) |
Dr. Francesca Barone M.D., Ph.D. | Chief Scientific Officer | 506.76k | 1978 (47 years) |
Ms. Ileen B. Winick | Chief People Officer | N/A | |
Ms. Susan Stewart J.D., L.L.M. | Chief Regulatory Officer | N/A | 1961 (64 years) |
Dr. William Garrett Nichols M.D., M.S. | Chief Medical Officer | N/A | 1969 (56 years) |
Mr. Charles Schoch | Interim CFO, Principal Accounting Officer, Treasurer & Secretary | N/A | 1985 (40 years) |
Dr. Paul-Peter Tak FOCIS, M.D., Ph.D. | President, CEO & Director | 1961 (64 years) |
Address: United States, Needham. MA, 117 Kendrick Street - open in Google maps, open in Yandex maps
Website: https://www.candeltx.com
Website: https://www.candeltx.com